基因工程抗体片段在肿瘤生物治疗中的研究进展
Progress in genetically engineered antibody fragments for tumor biotherapy
摘要
随着分子生物学和分子免疫学的飞速发展,涌现出了大量通过基因工程技术改造的人源化抗体片段。因其具有分子量小、穿透力强、抗原性低低,易于基因操作等特点而成为人们研究的热点。由于基因工程抗体片段具有良好的靶向性,因此在肿瘤的治疗中被广泛应用。
出处
《国外医学（肿瘤学分册）》
2005年第11期830-833,共4页
Foreign Medical Sciences (Cancer Section)
基金
湖南省卫生厅科研基金资助项目(A2003-001)
参考文献23
-
1Hudson PJ, Souriau C. Engineered antibodies. Nat Med,2003,9( 1 ):129-134.
-
2Kreitman RJ. Recombinant toxins for the treatment of cancer. Curr Opin Mol Ther,2003,5( 1 ) :44-51.
-
3Di Paolo C, Willuda J, Kubetzko S, et al. A recombinant immunotoxin derived from a humanized epithelial cell adhesion molecule-specific single-chain antibody fragment has potent and selective antitumor activity. Clin Cancer Res,2003,9 (7) :2837-2848.
-
4Bruell D, Bruns CJ, Yezhelyev M, et al . Recombinant anti-EGFR immunotoxin 425 (scFv)-ETA' demonstrates anti-tumor activity against disseminated human pancreatic cancer in nude mice. Int J Mol Med,2005,15(2) :305-313.
-
5Todhunter DA, Hall WA, Rustamzadeh E, et al. A bispecific immunotoxin ( DTAT13 ) targeting human IL- 13 receptor ( IL- 13 R) and urokinase-type plasminogen activator receptor (uPAR) in a mouse xenograft model. Protein Eng Des Sel ,2004,17 ( 2 ): 157-164.
-
6Shaik MS, Jackson TL, Singh M. Effect of monensin liposomes on the cytotoxicity of anti-My9-bR immunotoxin. J Pharm Pharmacol,2003, 55(6) :819-825.
-
7Helguera G, Penichet ML. Antibody-cytokine fusion proteins for the therapy of cancer. Methods Mol Med ,2005 ,109 :347-374.
-
8Heuser C, Guhlke S, Matthies A, et al. Anti-CD30-scFv-Fc-IL-2 antibody-cytokine fusion protein that induces resting NK cells to highly efficient cytolysis of Hodgkin's lymphoma derived tumour cells. Int J Cancer, 2004, 110(3) :386-394.
-
9Gillies SD, Lan Y, Brunkhorst B, et al . Bi-functional cytokine fusion proteins for geue therapy and antibody-targeted treatment of cancer. Cancer Immunol Immunother, 2002, 51 (8) :449-460.
-
10Yagita H, Takeda K, Hayakawa Y, et al. TRAIL and its receptors as targets for cancer therapy. Cancer Sci, 2004, 95 (10) :777-783.
-
1杨智炜,李永平.基因工程视网膜母细胞瘤动物模型的建立[J].中华眼科杂志,2006,42(7):667-670. 被引量：1
-
2冯建芳.BRCA1—小鼠胚胎必需的癌基因[J].自然杂志,1997,19(4):241-241.
-
3杨润祥,马飞,张灿珍.趋化因子及其受体在肿瘤转移中的作用[J].中国医学文摘（肿瘤学）,2006,20(1):60-61. 被引量：1
-
4吴奇,刘萍.反义寡核苷酸在肿瘤治疗中的应用[J].医学信息（中旬刊）,2010,5(8):2030-2031. 被引量：1
-
5杨栓盈,王双妮,杨德昌.肺癌早期诊断研究进展[J].国外医学（呼吸系统分册）,2002,22(1):25-27. 被引量：7
-
6叶奇鲁,于载泺.细胞因子在白血病研究中的应用[J].山西白血病,1992,1(1):52-55.
-
7张百红,岳红云.肿瘤免疫细胞靶向治疗的研究进展[J].西北国防医学杂志,2015,36(12):816-818. 被引量：1
-
8陈丽珍.复发性卵巢癌基因治疗一例的护理[J].中华国际护理杂志,2004,3(10):800-800.
-
9李凯,彭洪云.直肠癌原位小鼠模型的研究进展[J].结直肠肛门外科,2008,14(2):138-140.
-
10李永利,姚德茂.肿瘤疫苗研究的现状[J].现代肿瘤医学,2005,13(6):869-871.
